Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: Role of MIP-1α in lung pathology

Journal of Virology

Volumn 75, Issue 2, 2001, Pages 878-890

  Haeberle, H A ^a   Kuziel, W A ^a   Dieterich, H J ^a   Casola, A ^a   Gatalica, Z ^a   Garofalo, R P ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE; EOTAXIN; GAMMA CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN TCA3; RANTES; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LOWER RESPIRATORY TRACT INFECTION; LUNG INFILTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT MUCOSA; VIRUS PATHOGENESIS; VIRUS TITRATION;

ANIMALS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRUS REPLICATION;

EID: 0035158630     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.2.878-890.2001     Document Type: Article

References (47)

1. Pathological changes in virus infections of the lower respiratory tract in children
2. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages
3. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES
4. Nasal quantity of respiratory syncytial virus correlates with disease severity in hospitalized infants
5. Respiratory syncytial virus
6. Requirement of MIP-α for an inflammatory response to viral infection
7. The chemokine macrophage-inflammatory protein-1alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection
8. Role of respiratory viruses in childhood mortality
9. Macrophage inflammatory proteins: Biology and role in pulmonary inflammation
10. Sudden and unexpected deaths to infants: Histology and virology
11. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
12. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection
13. Clinical aspects of bronchial reactivity and cell-virus interaction
14. Primary respiratory syncytial virus infection in mice
15. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation
16. Respiratory syncytial virus infection in infants: Quantitation and duration of shedding
17. Respiratory syncytical virus-induced chemokine expression in the lower airways: Eosinophil recruitment and degranulation
18. Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells
19. Lymphotactin: A cytokine that represents a new class of chemokine
20. A plaque assay for respiratory syncytial virus
21. IL-8 release from human neutrophils by the respiratory syncytial virus is independent of viral replication
22. A novel signaling mechanism between gas and blood compartments of the lung
23. Biologic activities of the murine beta-chemokine TCA3
24. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease
25. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line
26. Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus
27. Immunopathological mechanisms in respiratory syncytial virus disease
28. Properties of the novel proinflammatory supergene 'intercrine' cytokine family
29. Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice
30. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
31. Cytokine-activated human endothelial cells synthesize and secrete monocyte chemoattractant protein, MCP-1
32. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells
33. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses
34. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1beta chemokines attract distinct populations of lymphocytes
35. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection
36. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease
37. Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: Relation to asthma and atopy
38. Primary respiratory syncytial virus infection: Pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model
39. GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice
40. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1alpha and MIP-1beta
41. Respiratory syncytial virus infection in mice
42. Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis
43. Respiratory syncytial virus: I. Concentration and purification of the infectious virus
44. Respiratory syncytial virus affects pulmonary function in BALB/c mice
45. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: Role in obstructive airway disease
46. The development of respiratory syncytial virus-specific IGE and the release of histamine in nasopharyngeal secretions after infection
47. Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin